Key Takeaways
- SAS Group has acquired Ceres Biotics, a Madrid-based company specializing in microbial biofertilizers and biostimulants.
- The acquisition strengthens SAS Group’s position in microbial biosolutions and supports its long-term expansion strategy.
- Ceres Biotics brings complementary products, established European market presence, and advanced R&D capabilities.
- The transaction follows a series of acquisitions since Stirling Square Capital Partners’ entry five years ago.
- Sustainability and innovation remain central to the company's growth strategy.
SAS Group Expands Biosolutions Strategy with Ceres Biotics Acquisition
SAS Group has announced the acquisition of Ceres Biotics, a Spain-based company focused on innovation in microbial biofertilizer and biostimulant solutions. Headquartered in Madrid, Ceres Biotics specializes in the development of microbial products designed to support agricultural productivity and soil health.
The acquisition represents a further step in the group’s expansion roadmap, which began five years ago following the entry of Stirling Square Capital Partners. Since then, SAS Group has completed multiple acquisitions, including Biovert in 2023, Pevesa Agroscience in 2024, and Aqua do Brasil and CODIAGRO last year.
Strengthening SAS Group's Capabilities in Microbial Biosolutions
With the addition of Ceres Biotics, SAS Group expands its presence in the growing microbial biosolutions segment. According to the company, Ceres Biotics brings a complementary product portfolio and strong expertise in microorganisms, alongside established customer relationships across Europe.
